Showing results (261-270 of 1,085) with videos related to
Sort By:
Pageof 109
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 10, 2006
"Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study"Pavel Cervinka, Marco A Costa, Dominick J Angiolillo, et al.British Journal of Clinical Pharmacology|November 11, 2018
Pharmacokinetic-pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patientsMagnus Åstrand, Carl Amilon, Daniel Röshammar, et al.Journal of the American College of Cardiology|April 8, 2017
Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac SurgerySubhash Banerjee, Dominick J Angiolillo, William E Boden, et al.Journal of the American College of Cardiology|December 17, 2013
Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2)Dominick J Angiolillo, Nicholas Curzen, Paul Gurbel, et al.The Journal of Invasive Cardiology|August 5, 2005
Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registryMarco Costa, Dominick J Angiolillo, Paul Teirstein, et al.European Heart Journal. Cardiovascular Pharmacotherapy|May 14, 2025
Sex-Related Variations in Platelet Reactivity in Presence or Absence of Antiplatelet TherapyMattia Galli, Sergio Terracina, Eleonora Schiera, et al.European Heart Journal|March 25, 2021
Antithrombotic therapy in diabetes: which, when, and for how long?Ramzi A Ajjan, Noppadol Kietsiriroje, Lina Badimon, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2012
Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus statusPiera Capranzano, Jose Luis Ferreiro, Masafumi Ueno, et al.American Heart Journal|April 18, 2022
Dual antiplatelet therapy duration after percutaneous coronary intervention using drug eluting stents in high bleeding risk patients: A systematic review and meta-analysisAakash Garg, Amit Rout, Serdar Farhan, et al.The Journal of Invasive Cardiology|April 10, 2008
Short- or long-term outcomes of coronary artery aneurysms occurring after directional coronary atherectomyYuji Oikawa, Junji Yajima, Dominick J Angiolillo, et al.Pageof 109